Compass Therapeutics Inc. <CMPX.O>: Wedbush Cuts to Neutral From Outperform; Cuts Target Price to $1 From $5
CMPX•Related News
China private crushers buy Australian canola, first deals since 2020
ADM•
Shipping traffic via Strait of Hormuz stays below 10-day average, data shows
XLE•
Royal Caribbean takes 50% stake in Sandals, Beaches resorts venture for USD 3 billion
RCL•
Jpmorgan Chase Explored Finding Partners To Approve And Take On The Risk Of Some Co-Branded Credit-Card Applications That The Bank Denies
JPM•
Snowflake EVP Product Management Christian Kleinerman disposes of common shares worth $1,595,344.76
SNOW•